Abdel-Fatah, T. M., Ball, G., Lee, A. H. S., Pinder, S., MacMilan, R. D., Cornford, E., Moseley, P. M., Silverman, R., Price, J., Latham, B., Palmer, D., Chan, A., Ellis, I. O., & Chan, S. Y. T. (2015). Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer. Clinical Cancer Research, 21(5), 1052-1062. https://doi.org/10.1158/1078-0432.ccr-14-0685